Toll-like receptor 9 (TLR9) genetic variants rs187084 and rs352140 confer protection from Behcet's disease among Iranians

被引:2
|
作者
Tadayon, Zahra [1 ]
Fazeli, Seyed Abolhassan Shahzadeh [2 ]
Gholijani, Nasser [3 ]
Daryabor, Gholamreza [3 ]
机构
[1] Univ Sci & Culture, Fac Basic Sci & Adv Technol Biol, Dept Mol & Cellular Biol, ACECR, Tehran, Iran
[2] ACECR, Royan Inst Reprod Biomed, Reprod Biomed Res Ctr, Dept Genet, Tehran, Iran
[3] Shiraz Univ Med Sci, Autoimmune Dis Res Ctr, Sch Med, POB 713451583, Shiraz, Iran
关键词
Autoimmunity; Behcet's disease; Toll-like receptor 9 (TLR9); Single nucleotide polymorphism (SNP); SYSTEMIC-LUPUS-ERYTHEMATOSUS; POLYMORPHISMS; SUSCEPTIBILITY; ASSOCIATION; DNA;
D O I
10.1186/s41927-024-00382-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundBehcet's disease (BD) is a multisystem and multifactorial autoimmune disease characterized by relapsing episodes of oral aphthae, genital ulcers, and ocular and skin lesions. Toll-like receptor 9 (TLR9) has pro-inflammatory roles and its genetic variants might be involved in the pathogenesis of inflammatory diseases. MethodsTwo hundred five BD patients and 207 age and sex-matched healthy controls were evaluated for TLR9 single nucleotide polymorphisms - 1486 T/C (rs187084) and + 2848:G/A (rs352140) using polymerase chain reaction-restriction fragment length polymorphism (RFLP-PCR). ResultsHealthy individuals had a significantly higher frequency of rs187084 AG and AG + GG genotypes than BD patients (p = 0.02 and p = 0.018; respectively). Of interest, healthy males had a significantly higher frequency of rs187084 AG + GG genotype and G allele than male BD patients (p = 0.035 and p = 0.045; respectively). However, rs187084 AG genotype and G allele frequencies were significantly higher in male patients with genital aphthous (p = 0.01 and p = 0.046; respectively). Furthermore, a significantly higher frequency of rs352140 CT and TT + CT genotypes was detected in healthy individuals than in BD patients (p = 0.01, and p = 0.032; respectively). Such results were also seen in healthy females than female patients (p = 0.001, and p = 0.004; respectively). Haplotype analysis revealed a significantly higher frequency of A-C and G-C haplotypes among patients and healthy subjects, respectively (p = 0.002 and p = 0.000; respectively). ConclusionOur data suggested that rs187084 AG and AG + GG genotypes and rs352140 CT and TT + CT genotypes protect Iranian individuals from BD but rs187084 AG genotype and G allele predispose male BD individuals to genital aphthous. However, additional studies are required to verify these results.
引用
收藏
页数:12
相关论文
共 39 条
  • [31] Toll-like receptor (TLR) 9 variant is associated with mother-to-child transmission (MTCT) of HIV-1 and TLR9 and TLR8 variants are associated with peak viral load in HIV-1-positive infants
    Beima-Sofie, K.
    Bigham, A.
    Lingappa, J. R.
    Wamalwa, D.
    Mackelprang, R. D.
    Maleche-Obimbo, E.
    Richardson, B.
    John-Stewart, G.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 20 - 21
  • [32] Toll-like receptor (TLR) expression in oral ulcer biopsies from Behcet's disease (BD) patients: A role for the innate immune system
    Murray, PI
    Durrani, OM
    Hamburger, J
    Williams, H
    Fortune, F
    Stewart, J
    Wallace, GR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [33] In vivo CpG administration accelerates graft-versus-host disease (GVHD) lethality by toll-like receptor 9 (TLR9) ligation of host antigen-presenting cells (APCs) and promotes allogeneic bone marrow (BM) rejection by TLR9 ligation of donor APCs.
    Blazar, Bruce R.
    Panoskaltsis-Mortari, Angela
    Krieg, Arthur M.
    Hemmi, Hiroaki
    Akira, Shizuo
    Serody, Jonathan
    Murphy, William J.
    Taylor, Patricia A.
    BLOOD, 2006, 108 (11) : 136A - 136A
  • [34] Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9):: frequencies, pairwise linkage disequilibrium, and haplotypes in three US ethnic groups and exploratory case-control disease association studies
    Lazarus, R
    Klimecki, WT
    Raby, BA
    Vercelli, D
    Palmer, LJ
    Kwiatkowski, DJ
    Silverman, EK
    Martinez, F
    Weiss, ST
    GENOMICS, 2003, 81 (01) : 85 - 91
  • [35] Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS)
    Tao, Yazhong
    Zhang, Xin
    Markovic-Plese, Silva
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 298 : 181 - 188
  • [36] Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial
    Schmoll, Hans-Joachim
    Wittig, Burghardt
    Arnold, Dirk
    Riera-Knorrenschild, Jorge
    Nitsche, Dieter
    Kroening, Hendrik
    Mayer, Frank
    Andel, Johannes
    Ziebermayr, Reinhard
    Scheithauer, Werner
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (09) : 1615 - 1624
  • [37] Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial
    Hans-Joachim Schmoll
    Burghardt Wittig
    Dirk Arnold
    Jorge Riera-Knorrenschild
    Dieter Nitsche
    Hendrik Kroening
    Frank Mayer
    Johannes Andel
    Reinhard Ziebermayr
    Werner Scheithauer
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 1615 - 1624
  • [38] Epistasis Between Toll-Like Receptor-9 Polymorphisms and Variants in NOD2 and IL23R Modulates Susceptibility to Crohn's Disease
    Toeroek, Helga P.
    Glas, Juergen
    Endres, Ilona
    Tonenchi, Laurian
    Teshome, Molla Y.
    Wetzke, Martin
    Klein, Wolfram
    Lohse, Peter
    Ochsenkuehn, Omas
    Folwaczny, Matthias
    Goeke, Burkhard
    Folwaczny, Christian
    Mueller-Myhsok, Bertram
    Brand, Stephan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (07): : 1723 - 1733
  • [39] Association Between Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease
    Vuono, Romina
    Kouli, Antonina
    Legault, Emilie M.
    Chagnon, Lauriane
    Allinson, Kieren S.
    La Spada, Alberto
    Biunno, Ida
    Barker, Roger A.
    Drouin-Ouellet, Janelle
    MOVEMENT DISORDERS, 2020, 35 (03) : 401 - 408